Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

更昔洛韦葡萄糖注射液 - NMPA Drug Approval Details

Approvals/NMPA/Ganciclovir and Glucose Injection

Approved

化学药品

Ganciclovir and Glucose Injection

河南医科大学制药厂🇨🇳 National Medical Products Administration

Approval Date: Jan 25, 2011
Approval ID: 800YawKxRAg
Company: 河南医科大学制药厂
Type: 化学药品

Approval Details

Approval Id: 800YawKxRAg
Approval Number: 国药准字H20060272
Generic Name: 更昔洛韦葡萄糖注射液
Generic Name En: Ganciclovir and Glucose Injection
Drug Type: 化学药品
Strength: 100ml:更昔洛韦0.1g与葡萄糖5.0g
Reg Date: 2011-01-25
Company Name: 河南医科大学制药厂
Production Company Address: 河南省郑州市高新技术产业开发区瑞达路86号
Company Detail Path: /organization/he-nan-yi-ke-da-xue-zhi-yao-han

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jan 25, 2011

Approval ID

800YawKxRAg

Type

化学药品

Back to NMPA Approvals